Triazole n-linked carbamoyl cyclohexyl acids as LPA antagonists
The present invention provides compounds of Formula (I): or a stereoisomer, tautomer, or pharmaceutically acceptable salt or solvate thereof, wherein all the variables are as defined herein. These compounds are selective LPA receptor inhibitors. 
Bristol-Myers Squibb Company
C A C C A C A C A A
C07C A61P C07D C07C A61P C07D A61P C07D A61P A61P
inventional additional inventional inventional inventional inventional additional inventional additional additional
Hao Lawrence J. Jun James R. Jun Peter Tai Wah Shiwei Yan Robert F. Ying
Zhang Kennedy Shi Corte Li Cheng Tao Shi Kaltenbach, III Wang